Table 6. Drug List for all breast cancer subtypes – X represents the appearance of the drug in the specific subtype.
LINCS Drugs | LuminalA | LuminalB | HER2 | TripleNegative |
---|---|---|---|---|
4-[4-(4-Fluorobenzyl)-1-piperidinyl]thieno[2,3-d]pyrimidine | X | |||
5-[(Benzyloxy)methyl]-7-(1-piperidinylmethyl)-8-quinolinol | X | X | ||
6-(2,3-Dihydro-1,4-benzodioxin-6-yl)-N-(3-methylbenzyl)-4-quinazolinamine | X | |||
CD-437 | X | X | X | |
chlorambucil | X | X | ||
cladribine | X | X | ||
etoposide | X | X | X | X |
gemcitabine | X | X | ||
heliomycin | X | |||
ingenol | X | X | ||
L-690488 | X | X | ||
lonidamine | X | |||
methylene-blue | X | X | ||
N-[(5-Bromo-8-hydroxy-7-quinolinyl)(2-thienyl)methyl]acetamide | X | |||
N-[(5-Fluoro-8-hydroxy-7-quinolinyl)(2-thienyl)methyl]acetamide | X | X | ||
PAC-1 | X | |||
palbociclib | X | X | ||
tunicamycin | X | |||
vorinostat | X | X | ||
wortmannin | X | X | X | X |
4-(keto-methyl-oxido-sulfuraniumyl)-3-nitro-benzoic | X | |||
benzamide | X | |||
benzydamine | X | |||
diphenyleneiodonium | X | |||
menadione | X | |||
NM-PP1 | X | |||
NVP-BEZ235 | X | |||
obatoclax | X | |||
quinoclamine | X | |||
RO-28-1675 | X | |||
serdemetan | X | |||
ZM-241385 | X | |||
aminopurvalanol-a | X | |||
barasertib | X | |||
cytarabine | X | X | ||
dasatinib | X | |||
entinostat | X | |||
fluticasone | X | |||
KIN001-055 | X | |||
purvalanol-a | X | |||
pyrvinium-pamoate | X | X | ||
SIB-1893 | X | X | ||
trichostatin-a | X | |||
triciribine | X | |||
tubastatin-a | X | X | ||
WZ-4002 | X | |||
(4E)-2-(4-Methoxyphenyl)-4-[(4-methoxyphenyl)imino]-4H-chromen-6-ol | X | |||
5-[(Benzyloxy)methyl]-7-(1-pyrrolidinylmethyl)-8-quinolinol | X | |||
chrysenequinone | X | |||
clobetasol | X | |||
cyclosporin-a | X | |||
idarubicin | X | |||
K784-3187 | X | |||
PLX-4720 | X | |||
teniposide | X | |||
WAY-170523 | X | |||
withaferin-a | X | |||
WYE-125132 | X |